Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Nikolaou

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
RSC Advances|May 14, 2026
Integrated triplex LFIA platform for decentralized molecular subtyping of breast cancerWenting Gao, Iftak Hussain, Theopisti A Nikolaou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 6, 2012
Identification and validation of gene expression models that predict clinical outcome in patients with early-stage laryngeal cancerE Fountzilas, K Markou, K Vlachtsis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 17, 1999
Paclitaxel and gemcitabine in advanced non-nasopharyngeal head and neck cancer: a phase II study conducted by the Hellenic Cooperative Oncology GroupG Fountzilas, G Stathopoulos, C Nicolaides, et al.
Chemical Communications (Cambridge, England)|December 15, 2015
Benefits of using BODIPY-porphyrin dyads for developing deep-red lighting sourcesM D Weber, V Nikolaou, J E Wittmann, et al.
Cancer Investigation|January 1, 1996
Cisplatin and continuous infusion of fluorouracil followed by radiation and weekly carboplatin in the treatment of locally advanced head and neck cancer: a Hellenic Cooperative Oncology Group studyG Fountzilas, P Kosmidis, K S Sridhar, et al.
Oral Oncology|February 28, 2012
Prognostic utility of angiogenesis and hypoxia effectors in patients with operable squamous cell cancer of the larynxG Pentheroudakis, I Nicolaou, V Kotoula, et al.
Cancer Causes & Control : CCC|March 1, 2008
Risk associations of melanoma in a Southern European population: results of a case/control studyVasiliki A Nikolaou, Vana Sypsa, Irene Stefanaki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 2011
Induction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemoradiotherapy in patients with nasopharyngeal carcinoma: a randomized phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluationG Fountzilas, E Ciuleanu, M Bobos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 23, 2006
Paclitaxel and gemcitabine vs. paclitaxel and pegylated liposomal doxorubicin in advanced non-nasopharyngeal head and neck cancer. An efficacy and cost analysis randomized study conducted by the Hellenic Cooperative Oncology GroupG Fountzilas, P Papakostas, U Dafni, et al.
The British Journal of Dermatology|July 21, 2022
Clinical associations and classification of immune checkpoint inhibitor-induced cutaneous toxicities: a multicentre study from the European Academy of Dermatology and Venereology Task Force of Dermatology for Cancer PatientsVasiliki A Nikolaou, Zoe Apalla, Cristina Carrera, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
RSC Advances|May 14, 2026
Integrated triplex LFIA platform for decentralized molecular subtyping of breast cancerWenting Gao, Iftak Hussain, Theopisti A Nikolaou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 6, 2012
Identification and validation of gene expression models that predict clinical outcome in patients with early-stage laryngeal cancerE Fountzilas, K Markou, K Vlachtsis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 17, 1999
Paclitaxel and gemcitabine in advanced non-nasopharyngeal head and neck cancer: a phase II study conducted by the Hellenic Cooperative Oncology GroupG Fountzilas, G Stathopoulos, C Nicolaides, et al.
Chemical Communications (Cambridge, England)|December 15, 2015
Benefits of using BODIPY-porphyrin dyads for developing deep-red lighting sourcesM D Weber, V Nikolaou, J E Wittmann, et al.
Cancer Investigation|January 1, 1996
Cisplatin and continuous infusion of fluorouracil followed by radiation and weekly carboplatin in the treatment of locally advanced head and neck cancer: a Hellenic Cooperative Oncology Group studyG Fountzilas, P Kosmidis, K S Sridhar, et al.
Oral Oncology|February 28, 2012
Prognostic utility of angiogenesis and hypoxia effectors in patients with operable squamous cell cancer of the larynxG Pentheroudakis, I Nicolaou, V Kotoula, et al.
Cancer Causes & Control : CCC|March 1, 2008
Risk associations of melanoma in a Southern European population: results of a case/control studyVasiliki A Nikolaou, Vana Sypsa, Irene Stefanaki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 2011
Induction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemoradiotherapy in patients with nasopharyngeal carcinoma: a randomized phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluationG Fountzilas, E Ciuleanu, M Bobos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 23, 2006
Paclitaxel and gemcitabine vs. paclitaxel and pegylated liposomal doxorubicin in advanced non-nasopharyngeal head and neck cancer. An efficacy and cost analysis randomized study conducted by the Hellenic Cooperative Oncology GroupG Fountzilas, P Papakostas, U Dafni, et al.
The British Journal of Dermatology|July 21, 2022
Clinical associations and classification of immune checkpoint inhibitor-induced cutaneous toxicities: a multicentre study from the European Academy of Dermatology and Venereology Task Force of Dermatology for Cancer PatientsVasiliki A Nikolaou, Zoe Apalla, Cristina Carrera, et al.
Pageof 5